| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
MNMD (MNMD) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. MNMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 778.5K | $10.23M | - | |
| CFO | 500.0K | - | - | |
| Other | 425.0K | $5.59M | - | |
| Other | 282.6K | $3.71M | - | |
| Dir | 75.2K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 26, 2025 | Karlin Daniel | Chief Medical Officer | Sell | 5,600 | $13.15 | $73,622.64 | -1.3% | |
| Dec 26, 2025 | Barrow Robert | Chief Executive Officer | Sell | 25,791 | $13.15 | $339,071.70 | -3.2% | |
| Dec 26, 2025 | Sullivan Mark | Chief Legal Officer | Sell | 11,276 | $13.15 | $148,244.44 | -3.8% | |
| Sep 25, 2025 | Sullivan Mark | Chief Legal Officer | Sell | 11,278 | $9.77 | $110,186.06 | -3.7% | |
| Sep 25, 2025 | Barrow Robert | Chief Executive Officer | Sell | 25,797 | $9.77 | $252,036.69 | -3.1% | |
| Sep 25, 2025 | Karlin Daniel | Chief Medical Officer | Sell | 7,704 | $9.77 | $75,268.08 | -1.8% | |
| Jun 25, 2025 | Sullivan Mark | Chief Legal Officer | Sell | 11,491 | $6.80 | $78,138.80 | -3.6% | |
| Jun 25, 2025 | Karlin Daniel | Chief Medical Officer | Sell | 7,848 | $6.80 | $53,366.40 | -1.8% | |
| Jun 25, 2025 | Barrow Robert | Chief Executive Officer | Sell | 26,491 | $6.80 | $180,138.80 | -3.1% | |
| Mar 25, 2025 | Barrow Robert | Chief Executive Officer | Sell | 21,208 | $6.74 | $142,941.92 | -2.4% |